scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.38) by 2.63 percent. This is a 54.17 percent decrease over losses of $(0.24) per share from the same period last year.
Wedbush Initiates Coverage On Sono Group with Neutral Rating, Announces Price Target of $4
Wedbush analyst Daniel Ives initiates coverage on Sono Group (NASDAQ:SEV) with a Neutral rating and announces Price Target of $4.
